MedPath

BORACELLE CAPSULES 500MG

BORACELLE CAPSULES 500MG

Discontinued
DIN Number

00702633

Drug Class

Human

Market Date

Dec 31, 1988

Company
HC

swiss herbal remedies ltd.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00702633
AIG Number0620490001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
V06DX OTHER COMBINATIONS OF NUTRIENTS
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification88:30.00*
Health Canada Classification

ACTIVE INGREDIENTS (6)

CIS-LINOLEIC ACID (BORAGE OIL)Active
Strength: 38.9 %
Monograph: CIS-LINOLEIC ACID (BORAGE OIL)
FATTY ACIDS (BORAGE OIL)Active
Strength: 7 %
Monograph: FATTY ACIDS (BORAGE OIL)
GAMMA-LINOLENIC ACID (BORAGE OIL)Active
Strength: 22.1 %
Monograph: GAMMA-LINOLENIC ACID (BORAGE OIL)
OLEIC ACID (BORAGE OIL)Active
Strength: 16.8 %
Monograph: OLEIC ACID (BORAGE OIL)
PALMITIC ACID (BORAGE OIL)Active
Strength: 11.5 %
Monograph: PALMITIC ACID (BORAGE OIL)
STEARIC ACID (BORAGE OIL)Active
Strength: 4 %
Monograph: STEARIC ACID (BORAGE OIL)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.